Tumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lung
about
Differential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to anti-angiogenic therapies.Expression of VEGFR2 and NRP-1 in non-small cell lung cancer and their clinical significanceVascular endothelial growth factor directly stimulates tumour cell proliferation in non-small cell lung cancer.Genetic polymorphisms in key hypoxia-regulated downstream molecules and phenotypic correlation in prostate cancer.Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumabGenetic alteration profiling of patients with resected squamous cell lung carcinomas.Fibroblast Growth Factor Receptor 1 (FGFR1), Partly Related to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) and Microvessel Density, is an Independent Prognostic Factor for Non-Small Cell Lung CancerVariability in Platelet-Derived Growth Factor Receptor Alpha Antibody Specificity May Impact Clinical Utility of Immunohistochemistry Assays.MALDI mass spectrometry imaging of erlotinib administered in combination with bevacizumab in xenograft mice bearing B901L, EGFR-mutated NSCLC cells.Analysis of Angiogenesis Biomarkers for Ramucirumab Efficacy in Patients with Metastatic Colorectal Cancer from RAISE, a Global, Randomized, Double-Blind, Phase III Study.Immunohistochemical application of a highly sensitive and specific murine monoclonal antibody recognising the extracellular domain of the human hepatocyte growth factor receptor (MET).Increased tumor vascularization is associated with the amount of immune competent PD-1 positive cells in testicular germ cell tumors.Design, Synthesis and Biological Activity Evaluation of S-Substituted 1-5-Mercapto-1,2,4-Triazole Derivatives as Antiproliferative Agents in Colorectal CancerEfficacy and safety of ramucirumab-containing chemotherapy in patients with pretreated metastatic gastric neuroendocrine carcinoma
P2860
Q33709284-0E760FAF-80EE-4515-BBCB-3E31FF645241Q34785969-ADDFDB20-82E4-4FC7-B02F-28C3C0EC81BDQ35939630-2E0CBAC0-30CA-469A-AB6B-D52CBBC29558Q36265638-A95D0897-6B00-42DB-B1CF-4F879103BC56Q37335124-6E40A110-C8B2-4E87-9635-53778D46C789Q37392781-FFDDA805-4B9D-4E56-9AD3-345A03A16418Q37603125-620F1DAA-AB88-4975-B650-25D702964086Q38731617-0C77CF0B-E0BC-4B2E-A7E3-816AF7EC84B6Q47114407-D04434C7-26E5-4943-90C8-9B6FAE5694B6Q49939667-801DFF07-7DE4-4046-870E-A47AD3A0F850Q53878549-46574A19-3122-4224-9E49-870231C38657Q55263819-2112DEA7-770C-49D8-80AB-63F1F961F232Q57167787-0AF4FCFD-078C-4A29-84A3-1C013F87C20FQ58694204-9C0ECC42-8D81-487F-94FC-F31C85E4ACB9
P2860
Tumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lung
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Tumor cell expression of vascu ...... ous cell carcinoma of the lung
@en
Tumor cell expression of vascu ...... us cell carcinoma of the lung.
@nl
type
label
Tumor cell expression of vascu ...... ous cell carcinoma of the lung
@en
Tumor cell expression of vascu ...... us cell carcinoma of the lung.
@nl
prefLabel
Tumor cell expression of vascu ...... ous cell carcinoma of the lung
@en
Tumor cell expression of vascu ...... us cell carcinoma of the lung.
@nl
P2093
P2860
P1433
P1476
Tumor cell expression of vascu ...... ous cell carcinoma of the lung
@en
P2093
Adarsh Joshi
Aejaz Nasir
Andrew E Schade
Angie D Fulford
Bradley L Ackermann
Drew M Nedderman
Gregory D Plowman
Laura E Benjamin
Rebecca R Hozak
Robert J Konrad
P2860
P304
P356
10.1371/JOURNAL.PONE.0080292
P407
P577
2013-11-14T00:00:00Z